Jeffrey Riley
Direttore/Membro del Consiglio presso GAIN THERAPEUTICS, INC.
Patrimonio netto: 38 400 $ in data 30/06/2024
Relazioni attive
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Matthias Alder | M | 59 |
GT Gain Therapeutics SA
 GT Gain Therapeutics SA Pharmaceuticals: MajorHealth Technology GT Gain Therapeutics SA operates as a preclinical stage biotech firm developing a class of next generation brain-penetrant non-competitive pharmacological chaperones for the treatment of devastating diseases using the proprietary SEE-Tx technology. Its projects include Beta-galactosidase GLB1 gene and Glucosylceramidase GBA gene. The company was founded by Lorenzo Leoni and is headquartered in Lugano, Switzerland. | 3 anni |
| Steven Shallcross | M | 62 | 9 anni | |
| Manolo Bellotto | M | 53 |
GT Gain Therapeutics SA
GT Gain Therapeutics SA Pharmaceuticals: MajorHealth Technology GT Gain Therapeutics SA operates as a preclinical stage biotech firm developing a class of next generation brain-penetrant non-competitive pharmacological chaperones for the treatment of devastating diseases using the proprietary SEE-Tx technology. Its projects include Beta-galactosidase GLB1 gene and Glucosylceramidase GBA gene. The company was founded by Lorenzo Leoni and is headquartered in Lugano, Switzerland. | 6 anni |
| Ryan N. Fiorini | M | - |
BlinkTBI, Inc.
 BlinkTBI, Inc. Data Processing ServicesTechnology Services Blinktbi, Inc. engages in the development of a eye test technology that provides objective data about neurological function to support medical personnel. The company was is headquartered in Charleston, SC. | 7 anni |
| Gianluca Fuggetta | M | 35 | 2 anni | |
| Nelson K. Stacks | M | 53 |
BlinkTBI, Inc.
BlinkTBI, Inc. Data Processing ServicesTechnology Services Blinktbi, Inc. engages in the development of a eye test technology that provides objective data about neurological function to support medical personnel. The company was is headquartered in Charleston, SC. | - |
| Douglas M. Carnes | M | - |
BlinkTBI, Inc.
BlinkTBI, Inc. Data Processing ServicesTechnology Services Blinktbi, Inc. engages in the development of a eye test technology that provides objective data about neurological function to support medical personnel. The company was is headquartered in Charleston, SC. | - |
| Khalid Islam | M | 67 |
GT Gain Therapeutics SA
GT Gain Therapeutics SA Pharmaceuticals: MajorHealth Technology GT Gain Therapeutics SA operates as a preclinical stage biotech firm developing a class of next generation brain-penetrant non-competitive pharmacological chaperones for the treatment of devastating diseases using the proprietary SEE-Tx technology. Its projects include Beta-galactosidase GLB1 gene and Glucosylceramidase GBA gene. The company was founded by Lorenzo Leoni and is headquartered in Lugano, Switzerland. | 7 anni |
| Eric Richman | M | 63 | 4 anni | |
| Dov Goldstein | M | 56 | 3 anni | |
| Hans-Peter Hasler | M | 68 | 3 anni | |
| Gwen Melincoff | M | 72 | 3 anni | |
| Claude Nicaise | M | 71 | 3 anni | |
| Harvey Schiller | M | 84 |
BlinkTBI, Inc.
BlinkTBI, Inc. Data Processing ServicesTechnology Services Blinktbi, Inc. engages in the development of a eye test technology that provides objective data about neurological function to support medical personnel. The company was is headquartered in Charleston, SC. | 6 anni |
| Michael Kaleko | M | - | 12 anni | |
| Aquilla S. Turk | M | - |
BlinkTBI, Inc.
BlinkTBI, Inc. Data Processing ServicesTechnology Services Blinktbi, Inc. engages in the development of a eye test technology that provides objective data about neurological function to support medical personnel. The company was is headquartered in Charleston, SC. | - |
| Michael Martino | M | 68 |
CaraVan Biologix
| - |
| Elena Cubero-Jorda | F | - | - | |
| Cynt Marshall | F | - |
BlinkTBI, Inc.
BlinkTBI, Inc. Data Processing ServicesTechnology Services Blinktbi, Inc. engages in the development of a eye test technology that provides objective data about neurological function to support medical personnel. The company was is headquartered in Charleston, SC. | - |
| Bob Branan | M | - |
BlinkTBI, Inc.
BlinkTBI, Inc. Data Processing ServicesTechnology Services Blinktbi, Inc. engages in the development of a eye test technology that provides objective data about neurological function to support medical personnel. The company was is headquartered in Charleston, SC. | - |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Charles Ballantyne | M | 64 | 5 anni | |
| Steven Kanzer | M | 59 | 13 anni | |
| Andrew Bristol | M | - | - | |
| Klaus Gottlieb | M | - | - | |
| Joseph A. Sliman | M | 51 | 5 anni | |
| George J. Brewer | M | - | - | |
| James Kuo | M | 58 | 5 anni | |
| Salvatore Calabrese | M | 54 | 3 anni | |
| Kris M. Maly | F | - | - | |
| Julie A. Caudill | F | - | - | |
| Scott Tarriff | M | 64 | 8 anni | |
| Carol R. Reed | M | 71 | 2 anni | |
| Lorenzo Leoni | M | - | 4 anni | |
| Deb Mathews | M | - | - | |
| Raymond Stapleton | M | - | 4 anni | |
| Maureen Early | F | - | - | |
| Xavier Barril | M | - | 6 anni | |
| Olivia Coughlin | M | - | - | |
| Lewis Barrett | M | - | 2 anni | |
| Roberto de Ponti | M | - |
GT Gain Therapeutics SA
GT Gain Therapeutics SA Pharmaceuticals: MajorHealth Technology GT Gain Therapeutics SA operates as a preclinical stage biotech firm developing a class of next generation brain-penetrant non-competitive pharmacological chaperones for the treatment of devastating diseases using the proprietary SEE-Tx technology. Its projects include Beta-galactosidase GLB1 gene and Glucosylceramidase GBA gene. The company was founded by Lorenzo Leoni and is headquartered in Lugano, Switzerland. | 1 anni |
| Heidi Whalen | F | - | - | |
| Isaac Bright | M | - | - | |
| David A. Newsome | M | - | 5 anni | |
| Roberto Barzi | M | 48 | 2 anni | |
| Marianne Bjordal | M | - | 1 anni |
Statistiche
| Paese | Relazioni | % del totale |
|---|---|---|
| Stati Uniti | 44 | 97.78% |
| Svizzera | 4 | 8.89% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Jeffrey Riley
- Contatti personali
